Tryptophan metabolism and hepatic encephalopathy. Studies on the sedative properties of oxindole.
Oxindole administration (1-100 mg/kg i.p.) to mammals decreases locomotor activity, reduces muscular tone and blood pressure and at larger doses causes coma and death. Utilizing both HPLC and GC/MS, we showed that oxindole is present in the blood, brain and other organs of several animal species, including humans. We demonstrated that oxindole is a tryptophan metabolite able to significantly decrease neuronal excitability by modifying the function of voltage-operated sodium channels. Its synthesis requires the availability of indole, which is formed in the gut. When liver function is impaired, a sufficient amount of indole reaches systemic circulation and is oxidized into oxindole, which seems to be one of the responsible agents for the neurological symptoms found in the course of liver impairment.
Mannaioni
G
G
Department of Preclinical and Clinical Pharmacology, University of Florence, Italy.
Carpenedo
R
R
Corradetti
R
R
Carlà
V
V
Venturini
I
I
Baraldi
M
M
Zeneroli
M L
ML
Moroni
F
F
D000818:Animals; D006501:Hepatic Encephalopathy / Q000188:drug therapy*; D006801:Humans; D006993:Hypnotics and Sedatives / Q000494:pharmacology; D007211:Indoles / Q000378:metabolism* / Q000633:toxicity*; D008322:Mammals; D009043:Motor Activity / Q000187:drug effects; D009474:Neurons / Q000187:drug effects / Q000502:physiology; D014364:Tryptophan / Q000378:metabolism*
D006993:Hypnotics and Sedatives; D007211:Indoles; D014364:Tryptophan